分娩期硬膜外镇痛暴露与子代孤独症谱系障碍风险
该研究为加拿大安大略省基于健康行政数据库的人群队列,纳入2006年4月1日至2014年3月31日经阴道分娩的65 0373对母婴,暴露为分娩期任何硬膜外或腰硬联合镇痛。主要结局为18月龄后诊断为孤独症谱系障碍(ASD)。暴露组ASD诊断率为1.8%(7546例),未暴露组为1.4%(3234例);粗HR 1.30(95%CI 1.25-1.36),IPTW调整后HR 1.14(95%CI 1.08-1.21)。事后分析结果定性一致。作者结论为分娩期硬膜外镇痛与子代ASD风险轻度升高相关,但生物学合理性不明,需谨慎解读。
要点
- 暴露组ASD诊断率为1.8%(7546例),未暴露组为1.4%(3234例);粗HR 1.30(95%CI 1.25-1.36),IPTW调整后HR 1.14(95%CI 1.08-1.21)。
- 暴露组ASD发病率为18.8/10000人年(95%CI 18.4-19.3),未暴露组为14.4/10000人年(95%CI 13.9-14.9)。
- 事后分析(限足月儿、母亲内条件分析、排除同期其他产时镇痛暴露、完整病例分析、替代ASD定义、治疗组平均效应估计)结果定性无差异。
- 作者结论:分娩期硬膜外镇痛与子代ASD风险轻度升高相关,但生物学合理性不明,需谨慎解读。
适用人群与场景
- 加拿大安大略省2006年4月1日至2014年3月31日经阴道分娩的单胎活产母婴对,共650373对;排除胎龄小于24周或体重小于500g的新生儿。
- 子代从18月龄随访至ASD诊断、失访或研究结束(2020年12月31日),以先发生者为准。
诊断标准与关键阈值
- 主要结局为18月龄后诊断为孤独症谱系障碍(ASD)。
- 暴露定义为分娩期任何硬膜外或腰硬联合镇痛暴露。
- 子代头部损伤作为对照结局。
研究设计与关键结果
- 研究类型为基于人群的队列研究,纳入650373对母婴,其中418761对(64.4%)暴露于分娩期硬膜外镇痛;母亲分娩时平均(SD)年龄29.7(5.5)岁,子代平均(SD)胎龄39.1(1.6)周,男婴329808例(50.7%)。
- IPTW后暴露组与未暴露组所有母婴特征相似(标准化差异<0.10)。
- 暴露组ASD诊断7546例(1.8%),发病率18.8/10000人年(95%CI 18.4-19.3);未暴露组诊断3234例(1.4%),发病率14.4/10000人年(95%CI 13.9-14.9)。
- 分娩期硬膜外镇痛与ASD的粗HR为1.30(95%CI 1.25-1.36),IPTW调整后HR为1.14(95%CI 1.08-1.21)。
- 事后分析(限足月儿、母亲内条件分析、排除同期其他产时镇痛暴露记录、完整病例分析、替代ASD定义、治疗组平均效应估计)结果定性无差异。
证据类型、等级与局限
- 证据类型:基于人群的队列研究,使用IPTW的Cox比例风险回归模型估计风险比。
- 局限:原文未报告局限性;作者在结论中指出该关联的生物学合理性仍不明确,发现必须谨慎解读。
对床旁实践的改变
- 作者认为分娩期硬膜外镇痛与子代ASD风险轻度升高相关,但生物学合理性不明,需谨慎解读;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: There is conflicting evidence on the association between intrapartum epidural analgesia and risk of autism spectrum disorder (ASD) in offspring.
OBJECTIVE: To evaluate the association between intrapartum epidural analgesia and the risk of ASD in offspring.
DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study was conducted in Ontario, Canada, using the health and administrative records of singleton live births by vaginal delivery between April 1, 2006, and March 31, 2014. Neonates with less than 24 weeks' gestation or weighing less than 500 g were excluded. Offspring were followed up from 18 months of age until ASD diagnosis, loss to follow-up, or the end of the study (December 31, 2020), whichever occurred first. Exposure, covariate, and outcome data were obtained using provincial health administrative databases.
EXPOSURES: Any intrapartum exposure to epidural or combined spinal-epidural analgesia.
MAIN OUTCOMES AND MEASURES: The primary outcome was ASD diagnosis after 18 months of age. Inverse probability of treatment weighting (IPTW) of Cox proportional hazards regression models was used to estimate the hazard ratio (HR) of intrapartum epidural analgesia and ASD in offspring. Offspring head injury was used as a control outcome. Models were adjusted for maternal sociodemographic factors, health behaviors, and medical and obstetrical history as well as labor, delivery, and offspring characteristics. Post hoc analyses included restriction to term neonates, a conditional within-mother analysis, exclusion of records with concomitant intrapartum pain management exposures, a complete case analysis, use of an alternative ASD definition, and estimation of the average treatment effect in the treated group.
RESULTS: Among the 650 373 mother-offspring pairs included in the study, 418 761 (64.4%) were exposed to intrapartum epidural analgesia. The mean (SD) maternal age at delivery was 29.7 (5.5) years; the offspring had a mean (SD) gestational age at delivery of 39.1 (1.6) weeks and included 329 808 male newborns (50.7%). The exposed and unexposed groups were similar in all maternal and newborn characteristics after IPTW (standardized difference <0.10). Autism spectrum disorder was diagnosed in 7546 offspring (1.8%) of mothers who received intrapartum epidural analgesia (incidence rate, 18.8 [95% CI, 18.4-19.3] per 10 000 person-years) compared with 3234 offspring (1.4%) who were unexposed (incidence rate, 14.4 [95% CI, 13.9-14.9] per 10 000 person-years). The crude HR for ASD associated with intrapartum epidural analgesia was 1.30 (95% CI, 1.25-1.36), and the IPTW-adjusted HR was 1.14 (95% CI, 1.08-1.21). Results did not qualitatively differ in post hoc analyses.
CONCLUSIONS AND RELEVANCE: Results of this study showed that intrapartum epidural analgesia was associated with a small increase in risk for ASD in offspring. The biological plausibility of this association, however, remains unclear, and the finding must be interpreted with caution.
参考来源
- Murphy MSQ, Ducharme R, Hawken S, et al. Exposure to Intrapartum Epidural Analgesia and Risk of Autism Spectrum Disorder in Offspring. JAMA Netw Open. 2022. PMID: 35616937. doi:10.1001/jamanetworkopen.2022.14273
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。